Tech-2437: Very Well-Established, Profitable CRO/SMO on the West Coast. This Company is a physician-owned and managed, independent, multi-site clinical Trial Management Organization. It is a full-service Site Management Organization (SMO) that conducts Phase I through Phase IV clinical trials in 12 therapeutic areas covering the full range of medical and scientific inquiry. The Company has several sites in four states, mostly in the western US. The owner is ready to stay on salary post-acquisition to help grow the Company and maintain client relationships.
- Revenue (2019): 3.51M
- Net Profit(2019): 1.0M
- Asking Price: $2.7M ; $1.5M down.